Thyroid dysfunction and takotsubo cardiomyopathy: a narrative review

1.Chae YK, Chiec L, Adney SK, et al. Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review. Oncotarget. 2018;9(46):28281-28289.

2.Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation. 2006;113(14):1807-16.

3.Khatiwada S, Boro H, Farooqui FA, et al. Endocrine causes of heart failure: A clinical primer for Cardiologists. Indian Heart J. 2021;73(1):14-21.

4.Eshtehardi P, Koestner SC, Adorjan P, et al. Transient apical ballooning syndrome—clinical characteristics, ballooning pattern, and long-term follow-up in a Swiss population. Int J Cardiol. 2009;135(3):370-5.

5.Strunk B, Shaw RE, Bull S, et al. High incidence of focal left ventricular wall motion abnormalities and normal coronary arteries in patients with myocardial infarctions presenting to a community hospital. J Invasive Cardiol. 2006;18(8):376-81.

6.Maruyama S, Nomura Y, Fukushige T, et al. Suspected takotsubo cardiomyopathy caused by withdrawal of bupirenorphine in a child. Circ J. 2006;70(4):509-11.

7.Kurisu S, Inoue I, Kawagoe T, et al. Presentation of Tako‐tsubo cardiomyopathy in men and women. Clin Cardiol. 2010;33(1):42-5.

8.Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008;155(3):408-17.

9.Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6): 539-48.

10.Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA. 2011;306(3):277-86.

11.Maas AH, Rosano G, Cifkova R, et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J. 2021;42(10):967-984.

12.Abraham J, Mudd JO, Kapur N, et al. Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol. 2009;53(15):1320-5.

13.Martin EA, Prasad A, Rihal CS, et al. Endothelial function and vascular response to mental stress are impaired in patients with apical ballooning syndrome. J Am Coll Cardiol. 2010;56(22):1840-6.

14.Nef HM, Möllmann H, Kostin S, et al. Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J. 2007;28(20):2456-64.

15.Morel O, Sauer F, Imperiale A, et al. Importance of inflammation and neurohumoral activation in Takotsubo cardiomyopathy. J Card Fail. 2009;15(3):206-13.

16.Kuo BT, Choubey R, Novaro GM. Reduced estrogen in menopause may predispose women to takotsubo cardiomyopathy. Gend Med. 2010;7(1):71-7.

17.Choudhry NK, Brennan T, Toscano M, et al. Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post–myocardial infarction secondary preventive therapies. Am Heart J. 2008;156(1):31-6.

18.Zaroff JG, Pawlikowska L, Miss JC, et al. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke. 2006;37(7):1680-5.

19.Pizzino G, Bitto A, Crea P, et al. Takotsubo syndrome and estrogen receptor genes: partners in crime? J Cardiovasc Med (Hagerstown). 2017; 18(4):268-276.

20.Vujovic KS, Stefanovic BS, Matic D, et al. Takotsubo Cardiomyopathy Precipitated By Thyroidectomy-A Case Report. Ser J Exp Clin Res. 22(2): 181-5.

21.Gupta S, Goyal P, Idrees S, et al. Association of endocrine conditions with takotsubo cardiomyopathy: a comprehensive review. J Am Heart Assoc. 2018;7(19):e009003.

22.Irigaray Echarri A, Ernaga Lorea A, Esparza Eguilaz N, et al. Takotsubo Syndrome and hyperthyroidism: a case report. An Sist Sanit Navar. 2019;42(2):215-220.

23.Rueda D, Aguirre R, Contardo D, et al. Takotsubo myocardiopathy and hyperthyroidism: a case report and literature Review. Am J Case Rep. 2017;18:865-870.

24.Murdoch D, O'callaghan W, Reda E, et al. Takotsubo cardiomyopathy associated with primary hyperthyroidism secondary to toxic multinodular goiter. Int J Angiol. 2016;25(5):e121-e122.

25.Patel K, Griffing GT, Hauptman PJ, et al. Recurrent takotsubo cardiomyopathy related to recurrent Thyrotoxicosis. Tex Heart Inst J. 2016;43(2):152-5.

26.Wu W-T, Hsu P-C, Huang H-L, et al. A case of Takotsubo cardiomyopathy precipitated by thyroid storm and diabetic ketoacidosis with poor prognosis. Acta Cardiol Sin. 2014;30(6):574-7.

27.Perkins MJ, Schachter DT. Biventricular Takotsubo cardiomyopathy in Graves hyperthyroidism. J Invasive Cardiol. 2014;26(3):E35-6.

28.Eliades M, El-Maouche D, Choudhary C, et al. Takotsubo cardiomyopathy associated with thyrotoxicosis: a case report and review of the literature. Thyroid. 2014;24(2):383-9.

29.Sarullo FM, Americo L, Accardo S, et al. Tako-tsubo cardiomyopathy observed in a patient with sepsis and transient hyperthyroidism. Monaldi Arch Chest Dis. 2009;72(1):33-6.

30.Kwon S-A, Yang JH, Kim M-K, et al. A case of Takotsubo cardiomyopathy in a patient with iatrogenic thyrotoxicosis. Int J Cardiol. 2010;145(3):e111-3.

31.Radhakrishnan A, Granato JE. An association between Takotsubo cardiomyopathy and thyroid storm. Postgrad Med. 2009;121(3):126-30.

32.Lee SJ, Kang JG, Ryu OH, et al. The relationship of thyroid hormone status with myocardial function in stress cardiomyopathy. Eur J Endocrino. 2009;160(5):799-806.

33.Balsa AM, Ferreira AR, Alves M, et al. Takotsubo cardiomyopathy associated with levothyroxine over-replacement. Eur Endocrinol. 2017;13(1):30-32.

34.Capel I, Tasa-Vinyals E, Cano-Palomares A, et al. Takotsubo cardiomyopathy in amiodarone-induced hyperthyroidism. Endocrinol Diabetes Metab Case Rep. 2017;2017:16-0116.

35.Aweimer A, El-Battrawy I, Akin I, et al. Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study. J Intern Med. 2021;289(5):675-687.

36.Trivieri MG, Oudit GY, Sah R, et al. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci U S A. 2006;103(15):6043-8.

37.Tang Y-D, Kuzman JA, Said S, et al. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation. 2005;112(20):3122-30.

38.Pantos C, Dritsas A, Mourouzis I, et al. Thyroid hormone is a critical determinant of myocardial performance in patients with heart failure: potential therapeutic implications. Eur J Endocrinol. 2007;157(4):515-20.

39.Pingitore A, Iervasi G, Barison A, et al. Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. J Card Fail. 2006;12(7):520-6.

40.Pingitore A, Galli E, Barison A, et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2008;93(4):1351-8.